Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Clinical trial NCT00631371 · COMPLETED

Trial details

NCT number: NCT00631371
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2008-04-01
Primary completion: 2012-04-01
Enrollment: 791

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.